Uravi Defence clarifies audit qualification impact on FY26 results
Uravi Defence and Technology reported a net profit of ₹213.98 crore for FY26, with a modified audit opinion due to reliance on unaudited accounts for new associate Spafax Group. The company clarified that the maximum quantifiable impact is a reversal of ₹72.05 lakh from net profit, pending receipt of audited statements.

*this image is generated using AI for illustrative purposes only.
Uravi Defence and Technology reported a net profit of ₹213.98 crore for the financial year ended March 31, 2026, in its audited consolidated results. The statutory auditors issued a modified opinion due to the inclusion of share of profit from a new associate, Spafax Group, based on unaudited management accounts. The company clarified there is no change or revision to the financial results previously submitted to the exchanges.
The modified opinion arises because Spafax International Holding Limited became an associate of the group on February 23, 2026, following the acquisition of more than 20% equity stake. The consolidated financial results include a share of profit of ₹72.05 lakh from this associate. However, the auditors were unable to obtain sufficient appropriate audit evidence as the audited financial statements of the Spafax Group were not available, necessitating reliance on unaudited management accounts.
The management stated that the precise impact of the qualification is unascertainable until audited financial statements are received. The maximum quantifiable impact on a gross basis is the reversal of the entire share of profit from the associate, amounting to ₹72.05 lakh, from the consolidated net profit. The company is actively pursuing the receipt of audited financial statements to incorporate any material adjustments in subsequent periods.
Financial Performance
For the year ended March 31, 2026, the company reported total income of ₹3,986.85 crore and total expenses of ₹3,900.63 crore. Profit before tax stood at ₹158.27 crore, while profit after tax was reported at ₹111.54 crore from continuing operations. The results include a profit of ₹102.44 crore from discontinued operations, primarily related to the sale of SKL India Private Limited, which ceased to be a subsidiary with effect from March 18, 2026.
The board approved the audited standalone and consolidated financial results at its meeting held on May 28, 2026. The statutory auditors, Viren Gandhi & Co., issued an unqualified opinion on the standalone financial results.
| Metric | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) |
|---|---|---|
| Total Income | 3,986.85 | 4,223.98 |
| Total Expenses | 3,900.63 | 3,968.55 |
| Net Profit | 213.98 | 254.43 |
| Earnings Per Share (Basic) | 0.92 | 2.31 |
Historical Stock Returns for Uravi Defence and Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.11% | -0.73% | -8.06% | -33.71% | -77.19% | -59.53% |
What is the expected timeline for receiving the audited financial statements of Spafax Group to resolve the modified audit opinion?
How will the discontinuation of SKL India Private Limited impact Uravi Defence's revenue streams and operational focus in FY27?
What strategic benefits does the company anticipate from the acquisition of the 20% stake in Spafax International Holding Limited?


































